Stocktoria
Candel Therapeutics, Inc. CADL
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-27
Candel Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1,060,086 | $5.2M | 1.93% |
| BlackRock Finance, Inc. | 823,071 | $5.1M | 1.5% |
| CITADEL ADVISORS LLC | 126,766 | $621,153 | 0.23% |
| Point72 Asset Management, L.P. | 107,211 | $525,334 | 0.2% |
| TWO SIGMA INVESTMENTS, LP | 93,500 | $458,150 | 0.17% |
| AQR CAPITAL MANAGEMENT LLC | 18,028 | $88,338 | 0.03% |
| RENAISSANCE TECHNOLOGIES LLC | 12,780 | $62,622 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.